PEER REVIEW COMMITTEE
In order to achieve the goal of distributing the samples from the Biorepository to investigators globally whose later-stage research targets shortening treatment times for TB drugs or identify biomarkers, the CTB2 developed a formal Peer Review Process. The Peer Review Process will be managed by a Peer Review Committee (PRC), a self-governed Committee which reports to the CTB2 and is dedicated to serving the goals of the Biorepository.
The PRC includes formal procedures for review of applications for samples from the Biorepository. Current Committee members are listed below. While members are listed, please direct contact to the Permanent Secretary or the address in the Application Process section.
Peer Review Committee Members and Their Affiliations |
|
Sufian Al Khaldi*, Senior Scientific Advisor, FDA |
|
Connie Benson, TB Clinical and Basic Research, ACTG |
|
Lei Fang, Biostatistician, Independent |
|
Jennifer Gardiner*, Biomarker Research,BMGF |
|
Judith Giri, Biorepository, Independent |
|
Daniella Livnat*, Infectious Disease, NIAID |
|
Stephen Murray, TB Clinical and Basic Research, TB Alliance |
|
Payam Nahid, TB Clinical and Basic Research, TBTC |
|
Gerhard Walzl, TB Basic Research, Independent |
|
Frank Weichold, Critical Path and Regulatory Science, FDA |
|
Connie Moreadith*, Permanent Secretary, Independent
|
|
Click to learn more about how to obtain samples through Biospecimen Access.

* Non-voting member